Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Research Network

Collaboration Network

14 collaborators·58 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Affiliations

University Hospital, Montpellier

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Rob Hyland, DPhil

Gilead Sciences

Moderately Similar
1 trials

Shared therapeutic areas:

Chronic HCV Infection
Similarity Score30%

Kathryn Kersey, MSc

Gilead Sciences

Moderately Similar
4 trials

Shared therapeutic areas:

Chronic HCV Infection
Similarity Score30%

Lai Wei, Doctor

Beijing Tsinghua Changgeng Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Chronic HCV Infection
Similarity Score30%

Robert H Hyland, DPhil

Gilead Sciences

Moderately Similar
3 trials

Shared therapeutic areas:

Chronic HCV Infection
Similarity Score30%

Lai Wei, Doctor

Peking University People's Hospital

Moderately Similar
3 trials

Shared therapeutic areas:

Chronic HCV Infection
Similarity Score30%

Shampa De-Oertel, PhD

Gilead Sciences

Moderately Similar
3 trials

Shared therapeutic areas:

Chronic HCV Infection
Similarity Score30%

Manal H El-Sayed, MD

Professor of Pediatric, Faculty of Medicine, Ain Shams University, Egypt

Moderately Similar
1 trials

Shared therapeutic areas:

Chronic HCV Infection
Similarity Score30%

Steven Knox

Gilead Sciences

Moderately Similar
3 trials

Shared therapeutic areas:

Chronic HCV Infection
Similarity Score30%

Didier SAMUEL

Hôpital Paul Brousse

Related
1 trials

Shared therapeutic areas:

Chronic HCV Infection

Worked with same sponsors:

Merck Sharp & Dohme LLCUniversity Hospital, Clermont-Ferrand
Collaborated on 1 trial
Similarity Score14%

Véronique LOUSTAUD RATTI

CHU LIMOGES

Related
1 trials

Shared therapeutic areas:

Chronic HCV Infection

Worked with same sponsors:

Merck Sharp & Dohme LLCUniversity Hospital, Clermont-Ferrand
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT02973503Phase 3PrincipalInvestigator

Study to Investigate the Efficacy of Elbasvir/Grazoprevir Fixed-Dose Combination for 8 Weeks in Treatment-Naïve, HCV GT1b-Infected Patients, With Non-severe Fibrosis

Chronic HCV Infection
Completed

All 1 trials loaded